Press Releases October 1, 2026 04:05 PM

Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026

Resmed Announces Q1 Fiscal 2027 Earnings Release Date and Webcast Details

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
RMD

Resmed plans to report its first quarter fiscal year 2027 financial and operational results on October 29, 2026, after market close. The company will host a webcast for investors and media to discuss the results and other forward-looking information.

Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026
RMD
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Earnings release scheduled for October 29, 2026, after NYSE close.
  • Webcast to discuss results and additional forward-looking information will be available online.
  • Resmed focuses on AI-powered digital health solutions, cloud-connected devices, and intelligent software for home healthcare.

SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2027 on Thursday, October 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.

Earnings webcast details:

  • Location:            https://investor.resmed.com
  • Date:                  Thursday, October 29, 2026
  • Time:                  1:30 p.m. PT / 4:30 p.m. ET
  • International:      London, Thursday, October 29, 2026, 8:30 p.m. GMT

                                   Sydney, Friday, October 30, 2026, 7:30 a.m. AEDT

Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.

A replay of the earnings webcast will be accessible on Resmed’s investor relations website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from October 29, 2026, until November 12, 2026, at:

  • U.S.: +1 877.660.6853
  • International: +1 201.612.7415
  • Conference ID: 13762822

About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.

For investors        For media+1 858.221.3304  +1 [email protected]     [email protected]

         
                            


Risks

  • Market reaction uncertainty since earnings details are not disclosed yet, creating potential volatility.
  • Dependence on continued innovation and adoption of digital health technologies in the competitive healthcare sector.
  • Potential regulatory and reimbursement risks affecting home healthcare devices and technology adoption.

More from Press Releases

Phillips Edison & Company Reaffirms Full Year 2026 Earnings Guidance; Increases Full Year 2026 Gross Acquisitions Guidance; Provides Investment Update Oct 1, 2026 JAKKS Pacific, Inc. Announces Third Quarter 2026 Earnings Call Oct 1, 2026 Business First Bancshares, Inc. Schedules Q3 2026 Earnings Release and Conference Call for Oct. 26 Oct 1, 2026 Phillips Edison & Company Announces $377.5 Million Expansion of Joint Venture with Northwestern Mutual Oct 1, 2026 ChronoScale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business Unit Oct 1, 2026